{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:26:48Z","timestamp":1792121208784,"version":"4.4.0"},"reference-count":56,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":845,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Cancer"],"published-print":{"date-parts":[[2013,10,15]]},"DOI":"10.1002\/ijc.28200","type":"journal-article","created":{"date-parts":[[2013,4,6]],"date-time":"2013-04-06T07:32:05Z","timestamp":1365233525000},"page":"1994-2003","source":"Crossref","is-referenced-by-count":43,"title":["Strong expression of survivin is associated with positive response to radiotherapy and improved overall survival in head and neck squamous cell carcinoma patients"],"prefix":"10.1002","volume":"133","author":[{"given":"Lovisa","family":"Farnebo","sequence":"first","affiliation":[{"name":"Department of ENT-Head and Neck Surgery; UHL, County Council of \u00d6sterg\u00f6tland; Link\u00f6ping; Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Tiefenb\u00f6ck","sequence":"additional","affiliation":[{"name":"Department of ENT-Head and Neck Surgery; UHL, County Council of \u00d6sterg\u00f6tland; Link\u00f6ping; Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ansell","sequence":"additional","affiliation":[{"name":"Division of Oto-Rhino-Laryngology and Head and Neck Surgery; Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Link\u00f6ping University; Link\u00f6ping; Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena K.","family":"Thunell","sequence":"additional","affiliation":[{"name":"Division of Cell Biology; Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Link\u00f6ping University; Link\u00f6ping; Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stina","family":"Garvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Roberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,5,9]]},"reference":[{"key":"10.1002\/ijc.28200-BIB0001|ijc28200-cit-0001","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1056\/NEJMra0707975","article-title":"Recent advances in head and neck cancer","volume":"359","author":"Haddad","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1002\/ijc.28200-BIB0002|ijc28200-cit-0002","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1600-0714.2011.01036.x","article-title":"Combining factors on protein and gene level to predict radioresponse in head and neck cancer cell lines","volume":"40","author":"Farnebo","year":"2011","journal-title":"J Oral Pathol Med"},{"key":"10.1002\/ijc.28200-BIB0003|ijc28200-cit-0003","first-page":"453","article-title":"Number of negative points: a novel method for predicting radiosensitivity in head and neck tumor cell lines","volume":"20","author":"Farnebo","year":"2008","journal-title":"Oncol Rep"},{"key":"10.1002\/ijc.28200-BIB0004|ijc28200-cit-0004","first-page":"7350","article-title":"Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma","volume":"62","author":"Ang","year":"2002","journal-title":"Cancer Res"},{"key":"10.1002\/ijc.28200-BIB0005|ijc28200-cit-0005","doi-asserted-by":"crossref","first-page":"927","DOI":"10.4161\/cbt.11.11.15525","article-title":"Studies on the inhibition of feline EGFR in squamous cell carcinoma: enhancement of radiosensitivity and rescue of resistance to small molecule inhibitors","volume":"11","author":"Bergkvist","year":"2011","journal-title":"Cancer Biol Ther"},{"key":"10.1002\/ijc.28200-BIB0006|ijc28200-cit-0006","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1158\/1078-0432.CCR-10-2120","article-title":"Vandetanib restores head and neck squamous cell carcinoma cells' sensitivity to cisplatin and radiation in vivo and in vitro","volume":"17","author":"Sano","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1002\/ijc.28200-BIB0007|ijc28200-cit-0007","first-page":"1935","article-title":"Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck","volume":"59","author":"Huang","year":"1999","journal-title":"Cancer Res"},{"key":"10.1002\/ijc.28200-BIB0008|ijc28200-cit-0008","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1038\/sj.bjc.6601402","article-title":"Survivin expression in oral squamous cell carcinoma","volume":"89","author":"Lo Muzio","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1002\/ijc.28200-BIB0009|ijc28200-cit-0009","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.canlet.2004.11.024","article-title":"Survivin as prognostic factor in squamous cell carcinoma of the oral cavity","volume":"225","author":"Lo Muzio","year":"2005","journal-title":"Cancer Lett"},{"key":"10.1002\/ijc.28200-BIB0010|ijc28200-cit-0010","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1600-0714.2009.00844.x","article-title":"Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma","volume":"39","author":"Kim","year":"2010","journal-title":"J Oral Pathol Med"},{"key":"10.1002\/ijc.28200-BIB0011|ijc28200-cit-0011","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s13277-011-0217-y","article-title":"High expression of survivin predicts poor prognosis in esophageal squamous cell carcinoma following radiotherapy","volume":"32","author":"Zhu","year":"2011","journal-title":"Tumour Biol"},{"key":"10.1002\/ijc.28200-BIB0012|ijc28200-cit-0012","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.suronc.2011.01.001","article-title":"Survivin expression and targeting in breast cancer","volume":"21","author":"Jha","year":"2011","journal-title":"Surg Oncol"},{"key":"10.1002\/ijc.28200-BIB0013|ijc28200-cit-0013","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11010-010-0525-3","article-title":"Prognostic significance of survivin expression in renal cell cancer and its correlation with radioresistance","volume":"344","author":"Lei","year":"2010","journal-title":"Mol Cell Biochem"},{"key":"10.1002\/ijc.28200-BIB0014|ijc28200-cit-0014","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/ijc.22380","article-title":"High survivin expression is associated with favorable outcome in advanced primary oral squamous cell carcinoma after radiation therapy","volume":"120","author":"Freier","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1002\/ijc.28200-BIB0015|ijc28200-cit-0015","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1600-0714.1997.tb00222.x","article-title":"p53 gene mutations and HPV infection in primary head and neck squamous cell carcinomas do not correlate with overall survival: a long-term follow-up study","volume":"26","author":"Riethdorf","year":"1997","journal-title":"J Oral Pathol Med"},{"key":"10.1002\/ijc.28200-BIB0016|ijc28200-cit-0016","first-page":"923","article-title":"Analysis of tumor suppressor p53 status in head and neck squamous cell carcinoma","volume":"11","author":"Smardova","year":"2004","journal-title":"Oncol Rep"},{"key":"10.1002\/ijc.28200-BIB0017|ijc28200-cit-0017","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/ijc.20042","article-title":"p53, p16 and cyclin D1: molecular determinants of radiotherapy treatment response in oral carcinoma","volume":"109","author":"Jayasurya","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1002\/ijc.28200-BIB0018|ijc28200-cit-0018","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/cncr.10232","article-title":"p53 and Ki-67 as markers of radioresistance in head and neck carcinoma","volume":"94","author":"Couture","year":"2002","journal-title":"Cancer"},{"key":"10.1002\/ijc.28200-BIB0019|ijc28200-cit-0019","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.cell.2004.11.022","article-title":"A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans","volume":"119","author":"Bond","year":"2004","journal-title":"Cell"},{"key":"10.1002\/ijc.28200-BIB0020|ijc28200-cit-0020","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.radonc.2008.03.018","article-title":"MDM2 SNP 309 and p53 codon 72 polymorphisms are associated with the outcome of oral carcinoma patients receiving postoperative irradiation","volume":"87","author":"Tu","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1002\/ijc.28200-BIB0021|ijc28200-cit-0021","first-page":"840","article-title":"Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele","volume":"62","author":"Bange","year":"2002","journal-title":"Cancer Res"},{"key":"10.1002\/ijc.28200-BIB0022|ijc28200-cit-0022","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/ijc.20204","article-title":"Involvement of the FGFR4 Arg388 allele in head and neck squamous cell carcinoma","volume":"111","author":"Streit","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1002\/ijc.28200-BIB0023|ijc28200-cit-0023","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.yexmp.2006.05.003","article-title":"The fibroblast growth factor receptor 4 (FGFR4) Arg388 allele correlates with survival in head and neck squamous cell carcinoma","volume":"82","author":"da Costa Andrade","year":"2007","journal-title":"Exp Mol Pathol"},{"key":"10.1002\/ijc.28200-BIB0024|ijc28200-cit-0024","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ctrv.2012.02.004","article-title":"The impact of pharmacogenetics on radiation therapy outcome in cancer patients. A focus on DNA damage response genes","volume":"38","author":"Borchiellini","year":"2012","journal-title":"Cancer Treat Rev"},{"key":"10.1002\/ijc.28200-BIB0025|ijc28200-cit-0025","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.dnarep.2007.08.006","article-title":"Modulation of DNA damage\/DNA repair capacity by XPC polymorphisms","volume":"7","author":"Zhu","year":"2008","journal-title":"DNA Repair"},{"key":"10.1002\/ijc.28200-BIB0026|ijc28200-cit-0026","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijrobp.2006.12.050","article-title":"Radiosensitivity of human fibroblasts is associated with amino acid substitution variants in susceptible genes and correlates with the number of risk alleles","volume":"68","author":"Alsbeih","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1002\/ijc.28200-BIB0027|ijc28200-cit-0027","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1200\/JCO.2005.04.6136","article-title":"High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma","volume":"24","author":"Licitra","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1002\/ijc.28200-BIB0028|ijc28200-cit-0028","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.radonc.2010.04.022","article-title":"The role of human papillomavirus in head and neck cancer and the impact on radiotherapy outcome","volume":"95","author":"Lassen","year":"2010","journal-title":"Radiother Oncol J Eur Soc Therap Radiol Oncol"},{"key":"10.1002\/ijc.28200-BIB0029|ijc28200-cit-0029","first-page":"72","article-title":"Expression of p16 protein is associated with human papillomavirus status in tonsillar carcinomas and has implications on survival","volume":"62","author":"Wittekindt","year":"2005","journal-title":"Adv Otorhinolaryngol"},{"key":"10.1002\/ijc.28200-BIB0030|ijc28200-cit-0030","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1023\/A:1008918223334","article-title":"Changing patterns of tonsillar squamous cell carcinoma in the United States","volume":"11","author":"Frisch","year":"2000","journal-title":"Cancer Causes Control"},{"key":"10.1002\/ijc.28200-BIB0031|ijc28200-cit-0031","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1136\/jcp.2003.008656","article-title":"HPV infections and tonsillar carcinoma","volume":"57","author":"Syrjanen","year":"2004","journal-title":"J Clin Pathol"},{"key":"10.1002\/ijc.28200-BIB0032|ijc28200-cit-0032","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/jnci\/92.9.709","article-title":"Evidence for a causal association between human papillomavirus and a subset of head and neck cancers","volume":"92","author":"Gillison","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1002\/ijc.28200-BIB0033|ijc28200-cit-0033","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0065-230X(05)93002-9","article-title":"Presence and influence of human papillomaviruses (HPV) in tonsillar cancer","volume":"93","author":"Dahlstrand","year":"2005","journal-title":"Adv Cancer Res"},{"key":"10.1002\/ijc.28200-BIB0034|ijc28200-cit-0034","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djn011","article-title":"Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial","volume":"100","author":"Fakhry","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1002\/ijc.28200-BIB0035|ijc28200-cit-0035","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/1097-0215(20000520)89:3<300::AID-IJC14>3.0.CO;2-G","article-title":"Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival","volume":"89","author":"Mellin","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1002\/ijc.28200-BIB0036|ijc28200-cit-0036","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1200\/JCO.2010.29.2904","article-title":"Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial","volume":"28","author":"Rischin","journal-title":"J Clin Oncol"},{"key":"10.1002\/ijc.28200-BIB0037|ijc28200-cit-0037","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1600-0714.2012.01177.x","article-title":"EGFR status and EGFR ligand expression influence the treatment response of head and neck cancer cell lines","volume":"42","author":"Jedlinski","year":"2012","journal-title":"J Oral Pathol Med"},{"key":"10.1002\/ijc.28200-BIB0038|ijc28200-cit-0038","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/sj.bjc.6600776","article-title":"Prognostic importance of survivin in breast cancer","volume":"88","author":"Kennedy","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1002\/ijc.28200-BIB0039|ijc28200-cit-0039","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s00432-005-0682-z","article-title":"Cellular localization of survivin: impact on the prognosis in colorectal cancer","volume":"131","author":"Ponnelle","year":"2005","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1002\/ijc.28200-BIB0040|ijc28200-cit-0040","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1053\/ejso.2002.1415","article-title":"Survivin expression in human osteosarcoma is a marker for survival","volume":"29","author":"Trieb","year":"2003","journal-title":"Eur J Surg Oncol"},{"key":"10.1002\/ijc.28200-BIB0041|ijc28200-cit-0041","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3892\/mmr.2012.755","article-title":"Effects and mechanism of downregulation of survivin expression by RNA interference on proliferation and apoptosis of lung cancer cells","volume":"5","author":"Chen","year":"2012","journal-title":"Mol Med Rep"},{"key":"10.1002\/ijc.28200-BIB0042|ijc28200-cit-0042","doi-asserted-by":"crossref","first-page":"974","DOI":"10.4161\/cbt.4.9.1914","article-title":"Downregulation of survivin by RNAi inhibits the growth of esophageal carcinoma cells","volume":"4","author":"Wang","year":"2005","journal-title":"Cancer Biol Ther"},{"key":"10.1002\/ijc.28200-BIB0043|ijc28200-cit-0043","first-page":"3579","article-title":"Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer","volume":"53","author":"Grandis","year":"1993","journal-title":"Cancer Res"},{"key":"10.1002\/ijc.28200-BIB0044|ijc28200-cit-0044","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1309\/BTLN5WTMJ3PCNRRC","article-title":"Expression of protein tyrosine kinases in head and neck squamous cell carcinomas","volume":"124","author":"Ongkeko","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1002\/ijc.28200-BIB0045|ijc28200-cit-0045","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/path.1642","article-title":"Frequent overexpression of multiple ErbB receptors by head and neck squamous cell carcinoma contrasts with rare antibody immunity in patients","volume":"204","author":"Bei","year":"2004","journal-title":"J Pathol"},{"key":"10.1002\/ijc.28200-BIB0046|ijc28200-cit-0046","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijrobp.2003.10.038","article-title":"Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy","volume":"59","author":"Chua","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1002\/ijc.28200-BIB0047|ijc28200-cit-0047","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ijrobp.2003.09.043","article-title":"The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck","volume":"58","author":"Eriksen","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1002\/ijc.28200-BIB0048|ijc28200-cit-0048","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1634\/theoncologist.2009-0058","article-title":"Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma","volume":"14","author":"Hama","year":"2009","journal-title":"Oncologist"},{"key":"10.1002\/ijc.28200-BIB0049|ijc28200-cit-0049","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0046-8177(99)90041-2","article-title":"Immunohistochemical detection of p53 protein accumulation in head and neck cancer: correlation with p53 gene alterations","volume":"30","author":"Taylor","year":"1999","journal-title":"Hum Pathol"},{"key":"10.1002\/ijc.28200-BIB0050|ijc28200-cit-0050","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0194-5998(95)70077-3","article-title":"Overexpression of p53 predicts organ preservation using induction chemotherapy and radiation in patients with advanced laryngeal cancer. Department of Veterans Affairs Laryngeal Cancer Study Group","volume":"113","author":"Bradford","year":"1995","journal-title":"Otolaryngology"},{"key":"10.1002\/ijc.28200-BIB0051|ijc28200-cit-0051","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/bjc.1998.632","article-title":"p53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma","volume":"78","author":"Mineta","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1002\/ijc.28200-BIB0052|ijc28200-cit-0052","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1001\/archoto.2010.47","article-title":"Prognostic impact of p16, p53, epidermal growth factor receptor, and human papillomavirus in oropharyngeal cancer in a betel nut-chewing area","volume":"136","author":"Al-Swiahb","year":"2010","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1002\/ijc.28200-BIB0053|ijc28200-cit-0053","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1034\/j.1600-0714.2000.290901.x","article-title":"The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck","volume":"29","author":"Nylander","year":"2000","journal-title":"J Oral Pathol Med"},{"key":"10.1002\/ijc.28200-BIB0054|ijc28200-cit-0054","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.oraloncology.2008.03.007","article-title":"Polymorphism of FGFR4 in cancer development and sensitivity to cisplatin and radiation in head and neck cancer","volume":"45","author":"Ansell","year":"2009","journal-title":"Oral Oncol"},{"key":"10.1002\/ijc.28200-BIB0055|ijc28200-cit-0055","first-page":"549","article-title":"Proteins and single nucleotide polymorphisms involved in apoptosis, growth control, and DNA repair predict cisplatin sensitivity in head and neck cancer cell lines","volume":"24","author":"Farnebo","year":"2009","journal-title":"Int J Mol Med"},{"key":"10.1002\/ijc.28200-BIB0056|ijc28200-cit-0056","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.ijrobp.2006.06.029","article-title":"Single-nucleotide polymorphisms in base excision repair, nucleotide excision repair, and double strand break genes as markers for response to radiotherapy in patients with Stage I to II head-and-neck cancer","volume":"66","author":"Carles","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.28200","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T12:04:28Z","timestamp":1715169868000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.28200"}},"subtitle":["Survivin predicts radiotherapy response"],"short-title":[],"issued":{"date-parts":[[2013,5,9]]},"references-count":56,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,10,15]]}},"URL":"https:\/\/doi.org\/10.1002\/ijc.28200","relation":{},"ISSN":["0020-7136"],"issn-type":[{"value":"0020-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5,9]]}}}